(Q54780478)

3 June 2018

title

Designing and implementing quality control for multi-center screening of mutations in the ATM gene among women with breast cancer. (English)

1 reference

3 June 2018

0 references

10

1 reference

3 June 2018

Patrick Concannon

14

1 reference

3 June 2018

Anne-Lise Børresen-Dale

4

object named as

Anne-Lise Børresen-Dale

1 reference

3 June 2018

11

Leslie Bernstein

1 reference

3 June 2018

1

Jonine L Bernstein

1 reference

3 June 2018

David P Atencio

9

object named as

David P Atencio

1 reference

3 June 2018

author name string

Sharon Teraoka

2

1 reference

3 June 2018

Robert W Haile

3

1 reference

3 June 2018

Barry S Rosenstein

5

1 reference

3 June 2018

Richard A Gatti

6

1 reference

3 June 2018

Anh T Diep

7

1 reference

3 June 2018

Laila Jansen

8

1 reference

3 June 2018

Susan L Teitelbaum

12

1 reference

3 June 2018

W Douglas Thompson

13

1 reference

3 June 2018

WECARE Study Collaborative Group

15

1 reference

3 June 2018

publication date

1 May 2003

1 reference

3 June 2018

published in

Human Mutation

1 reference

3 June 2018

volume

21

1 reference

3 June 2018

issue

5

1 reference

3 June 2018

page(s)

542-550

1 reference

3 June 2018

Dominant Negative ATM Mutations in Breast Cancer Families

cites work

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10206

Mortality rates among carriers of ataxia-telangiectasia mutant alleles

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10206

Incidence of cancer in 161 families affected by ataxia-telangiectasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10206

The ATM gene and breast cancer: is it really a risk factor?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10206

7 January 2021

Breast cancer and other cancers in Norwegian families with ataxia-telangiectasia

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10206

7 January 2021

New mutations, polymorphisms, and rare variants in the ATM gene detected by a novel SSCP strategy

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10206

7 January 2021

Reliability of DHPLC in mutational screening of ?-globin (HBB) alleles

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10206

7 January 2021

Requirement of ATM-dependent phosphorylation of brca1 in the DNA damage response to double-strand breaks

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10206

7 January 2021

Cancer risks in A-T heterozygotes

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10206

7 January 2021

Interpreting epidemiological research: blinded comparison of methods used to estimate the prevalence of inherited mutations in BRCA1.

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10206

7 January 2021

Localization of an ataxia-telangiectasia gene to chromosome 11q22-23.

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10206

7 January 2021

Cancer risk in ATM heterozygotes: a model of phenotypic and mechanistic differences between missense and truncating mutations

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10206

7 January 2021

Cancer risk in heterozygotes for ataxia-telangiectasia

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10206

7 January 2021

Evaluation of denaturing high performance liquid chromatography (DHPLC) for the mutational analysis of the neurofibromatosis type 1 ( NF1) gene.

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10206

7 January 2021

Cancer risk and the ATM gene: a continuing debate

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10206

7 January 2021

Mutations at the ataxia-telangiectasia locus and clinical phenotypes of A-T patients

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10206

7 January 2021

Functional link of BRCA1 and ataxia telangiectasia gene product in DNA damage response

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10206

7 January 2021

Evaluation and application of denaturing HPLC for mutation detection in Marfan syndrome: Identification of 20 novel mutations and two novel polymorphisms in the FBN1 gene

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10206

7 January 2021

Cancer in patients with ataxia-telangiectasia and in their relatives in the nordic countries

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10206

7 January 2021

A single ataxia telangiectasia gene with a product similar to PI-3 kinase

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10206

7 January 2021

Missense mutations but not allelic variants alter the function of ATM by dominant interference in patients with breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10206

7 January 2021

ATM mutations and phenotypes in ataxia-telangiectasia families in the British Isles: expression of mutant ATM and the risk of leukemia, lymphoma, and breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10206

7 January 2021

Breast and other cancers in families with ataxia-telangiectasia

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10206

7 January 2021

Increased frequency of ATM mutations in breast carcinoma patients with early onset disease and positive family history

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10206

7 January 2021

Global analysis of ATM polymorphism reveals significant functional constraint

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10206

7 January 2021

Genomic Organization of the ATM gene

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10206

7 January 2021

Denaturing high-performance liquid chromatography: A review

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10206

7 January 2021

Identifiers

DOI

10.1002/HUMU.10206

1 reference

3 June 2018

1 reference

3 June 2018